FGFR4 and chronic kidney disease: Although blockade of acute cardiac effects of FGF23 might be not desirable, anti-FGFR4 therapy may protect from chronic cardiac effects of FGF23 and associated progression to irreversible cardiac injury as observed in patients with CKD.